The United States Food and Drug Administration (FDA) authorized a new test for the detection of coronavirus through the breath of the person, who must blow a tube into a device the approximate size of a carry-on suitcase, the FDA reported.
The test gives results based on a chemical analysis in just three minutes, and its use could be applied to medical centers and hospitals, among others, the DPA news agency reported.
In preliminary tests, the test correctly detected 91 percent of people who were infected, while it identified 99 percent of cases who were not infected with the virus.
These tests, which included symptomatic and asymptomatic patients, “were performed with similar sensitivity in a follow-up clinical study focused on the omicron variant,” the FDA said in a statement.
With this test, a new version of the coronavirus detection tests is opened, which until now required nasal or throat samples.
